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Abstract
Background: Chylous leakage is a well-known complication after esophagectomy, but cervical chylous leakage is
relatively rare, and considerable controversy remains regarding the appropriate management strategies. We herein
report a case of cervical chylous leakage treated successfully by lipiodol lymphangiography.
Case presentation: The patient, a 70-year-old man with middle thoracic esophageal cancer, underwent radical
esophagectomy with 3-field lymph node dissection and subsequently developed cervical chylous leakage. From the
second postoperative day (POD2), the amount of fluid in the cervical drainage tube increased by 200–300 ml/day. We
started octreotide (300 μg/day) on POD5 and etilefrine (120 mg/day) on the POD6. However, the amount of cervical
discharge did not decrease. We performed lipiodol lymphangiography on POD8. Thereafter, the amount of cervical
discharge finally began to decrease. We removed the drainage tube on POD13, and the patient was discharged from
the hospital on POD23.
Conclusions: Our case suggests the clinical efficacy of lipiodol lymphangiography for cervical chylous leakage after
esophagectomy.
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Background
Chylous leakage is a complication that may occur after
esophagectomy, as a result of intraoperative injury or inad-
equate ligation of the thoracic duct, thus leading to chyl-
ous leakage. The reported incidence of this complication
varies between 1.3 and 3.4% after procedures involving the
thorax and neck [1, 2]. Undiagnosed postoperative chylous
leakage may lead to malnutrition, sepsis, and a high mor-
tality rate [3, 4]. Therefore, a prompt diagnosis and
optimum management are required. Recently, etilefrine
and octreotide have been reported to be effective in treat-
ing chylous leakage. However, conclusive findings regard-
ing the efficacy of this regimen have yet to be obtained.
We herein report a case of esophagectomy complicated by
cervical chylous leakage that we treated successfully with
lipiodol lymphangiography.
Case presentation
A 70-year-old man was referred to our hospital for the
surgical management of a tumor in the thoracic upper
esophagus. A physical examination and laboratory data
revealed no remarkable findings. Computed tomography
(CT) revealed that the tumor, which was located in the
upper thoracic esophagus, had not locally invaded other
organs, but there was a metastasis in the right recurrent
laryngeal nerve lymph node. Upper gastrointestinal en-
doscopy showed a 2.5-cm-long ulcerated type 2 tumor
in the upper thoracic esophagus. The extent of tumor
invasion was estimated to be T2. A histopathological
examination of a biopsy specimen revealed the lesion to
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be squamous cell carcinoma. Pathologic findings showed
squamous cell carcinoma of the esophagus, (cT2, N1, M0,
cStage II), determined based on the Japanese Classification
of Esophageal Cancer, 10th edition. Neoadjuvant chemo-
therapy consisting of cisplatin and 5-fluorouracil (FP) was
performed before surgery. The patient received 2 cycles of
the following regimen: intravenous infusions of cisplatin
(80 mg/m2) on Day 1 and continuous intravenous infusion
of 5-fluorouracil (800 mg/m2) from Days 1 to 5, every
4 weeks. The tumor and lymph node metastasis were re-
duced after two cycles, and the neoadjuvant chemotherapy
evaluation was deemed a partial response (PR).
The patient underwent subtotal esophagectomy and
three-field lymphadenectomy (mediastinal lympadenect-
omy accompanied with neck and abdominal lymphadenec-
tomy) via thoracoscopy and hand-assisted laparoscopy, and
esophagogastrostomy was performed for reconstruction at
the neck via the retrosternal route. The thoracic duct was
preserved, because the thoracic duct did not approach the
tumor and there was no remarkable damage to the thoracic
duct during the operation. The histological diagnosis was
moderately differentiated squamous cell carcinoma of the
esophagus (pT1b, N1, M0, pStage II) based on the Japanese
Classification of Esophageal Cancer, 10th edition.
Postoperatively (Fig. 1), a large amount of cervical effu-
sion discharge (100–450 ml/day) flowed continuously
from the cervical drainage tube. From the second postop-
erative day (POD2), due to the amount of discharge from
cervical drainage tube increasing by 200–300 ml/day, we
suspected chylous leakage at the neck point and adminis-
tered an elemental diet (Elental) via an intestinal fistula
catheter. But the amount of discharge did not decrease.
We started octreotide (300 μg/day) on the POD5 and eti-
lefrine (120 mg/day) on POD6. The amount of discharge
decreased only slightly, so we consulted a radiologist at
our hospital and performed lipiodol lymphangiography on
POD8. The bilateral inguinal lymph nodes were directly
accessed under ultrasound guidance with a 23-gauge nee-
dle. Lipiodol was manually injected at about 1 ml per
5 min. The lipiodol injection was observed under fluoro-
scopic guidance in order to confirm appropriate access by
the needle (Fig. 2a). After approximately 10 ml of lipiodol
had been injected, a fluoroscopic image showed accumu-
lation of the lipiodol at the ductus thoracicus (Fig. 2b).
A day after lymphangiography, CT showed the accu-
mulation of lipiodol at the left venous angle (Fig. 3).
After lymphangiography, the amount of discharge from
the cervical drainage tube decreased immediately. On
POD9 (1 day after lymphangiography), the patient re-
sumed normal enteral nutrition via the intestinal fistula
catheter. On POD10 (2 days after lymphangiography),
the cervical discharge disappeared. On POD13 (5 days
after lymphangiography), the drainage tube was
removed. Cervical discharge was not seen at all after the
removal of the tube. On POD22 (14 days after lymph-
angiography), the patient was discharged home.
Discussion
Postoperative chylous leakage is a rare but well-known
complication of general surgery. The reported incidence
of this complication varies between 1.3 and 3.4% after pro-
cedures involving the thorax and neck [1, 2]. Prophylactic
ligation of thoracic duct during the radical resection of
esophageal cancer is usually used to prevent and treat
chylous leakage. But, there is dispute about prophylactic
ligation of the thoracic duct. Fu et al. showed a statistically
significant increase in postoperative chylous leakage fol-
lowing ligation, suggesting that prophylactic thoracic
ligation was not only unnecessary but also harmful [3].
Fig. 1 Postoperative progress and amount of discharge from cervical drainage tube
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Basically, we preserve the thoracic duct other than the
case that a tumor approaches it.
Chylous leakage can be life-threatening because of the
significant loss of fluid, plasma protein, fat, and immu-
noregulatory lymphocytes, and affected patients exhibit
clinical features of severe malnutrition, hyponatremia,
acidosis, hypocalcaemia and susceptibility to infection.
Therefore, the mortality rate is high in patients with un-
controlled chylous leakage [4, 5]. The initial treatment of
chylous leakage is usually conservative therapy, such as
fasting, a modified diet (low-fat, medium-chain triglycer-
ides; parenteral nutrition; and supplemental elements),
drainage of effusion, and the administration of octreotide
[6, 7] and etilefrine [8]. If conservative therapy fails, sur-
gical interventions such as thoracic duct ligation should
be considered. However, the thoracic duct and site of
chylous leakage are often difficult to locate during reop-
eration. In addition, because such surgery is considered
to increase the risk of complications, great care must be
taken during reoperation.
Lipiodol lymphangiography is traditionally a diagnostic
tool for identifying chylous leakage, allowing for the de-
tection of the leakage point if surgical intervention is
needed [5, 9]. However, lipiodol lymphangiography can
also be used as a treatment method itself and not merely
to obtain a diagnosis. Even when pleural drainage
exceeded 500 ml/day, lipiodol lymphangiography proved
an effective treatment in 35% of patients with chy-
lothorax. The successful treatment rate in patients with
failed non-surgical treatment was reported to be 51%
[10]. Matsumoto et al. reported that 89% patients with
postoperative chylous leakage needed no surgical rein-
tervention and that chylous leakage stopped after lipio-
dol lymphangiography [5]. The mechanism of chylous
leakage cessation after lipiodol lymphangiography was
suspected to involve the accumulation of lipiodol at the
leakage point, inducing an inflammatory reaction and
acting as an embolic agent [10].
The traditional procedure of lymphangiography involves
the subcutaneous injection of an oily contrast medium,
such as lipiodol, into each foot. The traditional procedure
has some problems. First by, it is an invasive procedure re-
quiring dorsal incisions, so that it has the potential to lead
infection associated with the incisions. Secondly, it is tech-
nically challenging because it requires the isolation and
cannulation of the fine pedal lymphatic vessels. Even after
successful placement of lymphangiogram needles, min-
imal movement of the patient can dislodge the needles.
Whereas, Intranodal lymphangiography using ultrasound
is a less-invasive approach in terms of requiring no inci-
sion compared to the traditional procedure. Intranodal
lymphangiography is simpler and easier because an in-
guinal node is directly accessed under ultrasound guid-
ance with a 23- gauge to 26-gauge spinal needle with use
of a local anesthesia [11, 12].
We performed lipiodol lymphangiography using
ultrasound-guided bilateral inguinal lymph node punc-
ture in our patient with cervical chylous leakage
Fig. 2 Lipiodol lymphangiography. The injected lipiodol flowed up through the lymph duct via the bilateral inguinal lymph nodes (a). A fluoroscopic
image obtained after 10 ml of lipiodol was injected shows the accumulation of lipiodol at the ductus thoracicus (arrowhead) (b)
Fig. 3 Coronal sections by CT obtained a day after lipiodol
lymphangiography show the accumulation of lipiodol at the left
venous angle (arrowhead)
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following esophagectomy and successfully treated his cer-
vical chylous leakage. Although there are several reports de-
scribing lipiodol lymphangiography as effective against
thoracic chylous leakage, few have described the effective
treatment of cervical chylous leakage using this technique.
In the otolaryngology region, Neel et al. reported a case that
was treated against the cervical chylous leakage after laryn-
gectomy with bilateral selective neck dissection using bilat-
eral pedal lymphangiography with iodinated oily contrast
medium [13]. But there are few other reports that were
treated with lymphangiography, there are many reports
treated with thoracic duct ligation for cervical chylous
leakage in after the head and neck surgery. Our case dem-
onstrated that lipiodol lymphangiography using ultrasound-
guided bilateral inguinal lymph node puncture can indeed
be an effective conservative treatment not only for thoracic
chylous leakage, but also for cervical chylous leakage.
The limitations of a single case report must be acknowl-
edged; although the proposed benefits of lipiodol lymph-
angiography by bilateral inguinal lymph node puncture
may indeed increase the utilization of thoracic duct
embolization, firm conclusions regarding its safety and ef-
ficacy require further investigation in a prospective series.
Cervical chylous leakage is relatively rare, and consider-
able controversy remains regarding the appropriate man-
agement strategies. Our case suggests the clinical efficacy of
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